According to Galectin Therapeutics's latest financial reports the company's current earnings (TTM) are -โน3.72 B. In 2023 the company made an earning of -โน3.45 B a decrease over its 2022 earnings that were of -โน3.26 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.